Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
Webinar :Join an expert panel for a webinar on Smart investments for a secure retirement January 28, 2021. Register now!
you are here: HomeNewsWorld

AstraZeneca's lung cancer treatment gets FDA nod

The combo treatment has been approved in the United States for adult patients with extensive-stage small cell lung cancer, the company said.

March 30, 2020 / 01:53 PM IST
Representative image

Representative image

The US Food and Drug Administration approved AstraZeneca Plc's combo treatment for a form of lung cancer in previously untreated patients, the drugmaker said on Monday.

The combo treatment has been approved in the United States for adult patients with extensive-stage small cell lung cancer, the company said.

The approval was based on results from a late-stage study in which the treatment showed a statistically significant improvement in overall survival in lung cancer patients when compared to standard of care, the company said.

Small cell lung cancer is a highly aggressive, fast-growing form of cancer that typically recurs and progresses rapidly despite initial response to chemotherapy.

Lung cancer is the leading cause of cancer deaths among both men and women and accounts for about one fifth of all cancer deaths.
Reuters
first published: Mar 30, 2020 01:47 pm

stay updated

Get Daily News on your Browser
Sections